Prostate cancer
Open
Phase 3
This trial is comparing partial ablation treatment with radical treatment for prostate cancer. Radical treatment includes:
It is open to people who have intermediate risk prostate cancer in only 1 side of their prostate.
Recruitment start: 1 April 2023
Recruitment end: 30 March 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Richard J Bryant
University of Oxford
National Institute for Health Research (NIHR)
University of Bristol (Qualitative Research Integrated within Trials (QuinteT); the Information Study)
AngioDynamics
EDAP-TMS
Last reviewed: 28 May 2025
CRUK internal database number: 16746